J B Chemicals & Pharmaceuticals executives retire

0 min read Updated on 01 Jul 2026, 04:59 AM

Reviewed by

Shriram SScanX News Team

AI Summary

J B Chemicals & Pharmaceuticals Ltd disclosed the retirement of Mr. Pradeep Kumar Singh, President Global Business, and Mr. Suresh Bhise, Vice President – IT, effective June 30, 2026. The cessation was reported under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

*this image is generated using AI for illustrative purposes only.

J B Chemicals & Pharmaceuticals Ltd announced the retirement of two senior management personnel effective June 30, 2026. Mr. Pradeep Kumar Singh, President Global Business, and Mr. Suresh Bhise, Vice President – IT, have retired from the services of the company. Consequently, they have ceased to be Senior Management Personnel with effect from the close of business hours on June 30, 2026.

The disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification references the SEBI Master Circular bearing reference no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and No. CIR/CFD/CMD/4/2015 dated September 09, 2015.

The table below details the changes in the senior management personnel:

Sr. No.	Disclosure requirement	Mr. Pradeep Kumar Singh	Mr. Suresh Bhise
1	Reason for change	Retirement	Retirement
2	Date of cessation	With effect from the closing of business hours of June 30, 2026	With effect from the closing of business hours of June 30, 2026

The filing was submitted by Sandeep Phadnis, Vice President – Secretarial & Company Secretary.

Historical Stock Returns for J B Chemicals and Pharmaceuticals

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.87%	+5.38%	+11.03%	+27.79%	+44.09%	+153.96%

Who will succeed Mr. Pradeep Kumar Singh to lead global business operations?

How will the company ensure continuity in IT strategy following Mr. Bhise's retirement?

What is the timeline for announcing the new leadership structure?

Read Next Article

J B Chemicals & Pharmaceuticals holds 50th AGM

1 min read Updated on 18 Jun 2026, 12:18 AM

Reviewed by

Ashish TScanX News Team

Add as a preferred
source on Google

AI Summary

J B Chemicals & Pharmaceuticals Limited held its 50th Annual General Meeting on June 17, 2026, via video conference. Shareholders approved the audited financial statements for FY26, confirmed an interim dividend of ₹12.70 per share, and declared a final dividend of ₹9.30 per share. The meeting, chaired by Mr. Arun Duggal, saw the re-appointment of a director and addressed shareholder queries.

*this image is generated using AI for illustrative purposes only.

J B Chemicals & Pharmaceuticals Limited conducted its 50th Annual General Meeting on June 17, 2026, via video conference. The meeting was held in compliance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholders approved the adoption of audited financial statements for the year ended March 31, 2026, confirmed an interim dividend of ₹12.70 per share, and declared a final dividend of ₹9.30 per share.

The remote e-voting process commenced on June 14, 2026, and concluded on June 16, 2026. The Board appointed Mr. Rajesh Parekh and Ms. Aishwarya Parekh as scrutinizers to oversee the voting process. A total of 74,579 shareholders were on record as of the cut-off date, with 60 members present in person through VC/OAVM. The meeting was chaired by Mr. Arun Duggal.

Voting Results Summary

Resolution Description	Votes For	Votes Against	% For
Adoption of Financial Statements	134,006,581	23	100.00
Confirmation of Interim Dividend	134,028,537	23	100.00
Declaration of Final Dividend	134,028,512	48	100.00
Re-appointment of Director	133,790,983	217,055	99.84

Meeting Details

Particulars	Details
Meeting Type	50th Annual General Meeting
Date	June 17, 2026
Time	3.00 P.M. IST
Mode	Video Conference (VC) / Other Audio Visual Means (OAVM)
Chairman	Mr. Arun Duggal
Total Shareholders on Record	74,579

The resolutions were passed with the requisite majority. Mr. Kaushal Singh Solanki, Chief Financial Officer, addressed queries from shareholders regarding the company's accounts and operations. The Statutory Auditors' Report and the Secretarial Audit Report contained no qualifications or adverse observations.

Historical Stock Returns for J B Chemicals and Pharmaceuticals